Search

Stamulumab

MYO-029 is a human anti-GDF-8 monoclonal antibody, which is being developed to treat muscle-wasting diseases including muscular dystrophy and age-related sarcopenia.

Tezacitabine

A synthetic purine nucleoside analogue with potential antineoplastic activity.

LGD-1550

LGD-1550 is an orally-active synthetic aromatic retinoic acid agent with potential antineoplastic and chemopreventive activities.

Glibornuride

Glibornuride is a sulfonylurea-type anti-diabetic drug.

Prednisolone caproate

Carbarsone

Carbarsone is a compound used as an antiprotozoal drug for the treatment of histomoniasis (or blackhead disease) in addition to other infectious diseases in chicken and turkeys. … It belongs to the _organoarsenic_ group of chemical compounds and has antiamebic properties.

Ompenaclid

RGX-202 is a recombinant AAV8 that contains a vector genome encoding a miniaturized dystrophin protein (microdystrophin).

Allogeneic Cardiosphere-Derived Cells

They exert their effects by secreting exosomes: nanometer-sized, membrane-bound vesicles used for the purpose of cell-cell communication. … TNFa, IFN-y, IL-1B, and IL-15). The anti-inflammatory effects of CDC work through polarizing macrophages and restoring tissue function.

Human ciliary neurotrophic factor, recombinant (E. coli)

Human ciliary neurotrophic factor, recombinant was investigated for macular telangiectasia in two clinical trials. … The trials were NCT03071965, an extension study of the NT-501 CNTF implant for macular telangiectasia, and NCT01949324, a Phase 2 multicenter randomized clinical trial of CNTF for macular telangiectasia

BCc1

BCc1 is a nanomedicine that demonstrated potent anticancer effects in both in vitro and in vivo studies.